| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.98B | 47.06B | 45.36B | 42.91B | 39.80B | 34.77B |
| Gross Profit | 9.02B | 9.62B | 9.80B | 9.28B | 8.52B | 7.28B |
| EBITDA | 4.18B | 4.56B | 4.79B | 4.21B | 3.86B | 2.80B |
| Net Income | 2.46B | 2.65B | 2.94B | 2.59B | 2.37B | 1.65B |
Balance Sheet | ||||||
| Total Assets | 39.77B | 40.54B | 41.63B | 40.35B | 36.88B | 33.65B |
| Cash, Cash Equivalents and Short-Term Investments | 11.50B | 14.16B | 14.60B | 12.62B | 10.18B | 10.36B |
| Total Debt | 1.12B | 68.00M | 85.00M | 104.00M | 125.00M | 150.00M |
| Total Liabilities | 15.67B | 12.91B | 14.53B | 15.38B | 13.89B | 12.52B |
| Stockholders Equity | 24.10B | 27.63B | 27.10B | 24.96B | 22.99B | 21.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.82B | 3.11B | 3.52B | 501.00M | 1.65B |
| Operating Cash Flow | 0.00 | 2.61B | 3.56B | 4.11B | 817.00M | 1.90B |
| Investing Cash Flow | 0.00 | -10.44B | -788.00M | -934.00M | -471.00M | -304.00M |
| Financing Cash Flow | 0.00 | -2.12B | -785.00M | -732.00M | -527.00M | -539.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥134.67B | 9.90 | ― | 1.92% | 15.22% | 29.56% | |
73 Outperform | ¥43.22B | 14.89 | ― | 3.74% | 4.73% | 17.57% | |
69 Neutral | ¥86.41B | 13.57 | ― | 3.65% | 6.94% | -11.05% | |
67 Neutral | ¥24.01B | 9.56 | ― | 7.56% | 3.74% | -10.06% | |
66 Neutral | ¥123.00B | 10.42 | 12.89% | 3.40% | 2.68% | 23.60% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥5.77B | 4.98 | ― | 4.13% | 4.55% | -12.71% |